Pandemic pharmaceutical dosing effects on wastewater treatment: No adaptation of activated sludge bacteria to degrade the antiviral drug Oseltamivir (Tamiflu®) and loss of nutrient removal performance

FEMS Microbiology Letters

Volumn 315, Issue 1, 2011, Pages 17-22

  Slater, Frances R ^a   Singer, Andrew C ^b   Turner, Susan ^c   Barr, Jeremy J ^a   Bond, Philip L ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b CENTRE FOR ECOLOGY AND HYDROLOGY   (United Kingdom)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Antiviral degradation; Enhanced biological phosphorus removal (EBPR); Pharmaceutical ecotoxicity

Indexed keywords

AMOXICILLIN; ERYTHROMYCIN; LEVOFLOXACIN; OSELTAMIVIR;

ACTIVATED SLUDGE; ADAPTATION; ARTICLE; BIOREMEDIATION; COMMUNITY STRUCTURE; DRUG CONCENTRATION; DRUG DEGRADATION; ECOTOXICOLOGY; MICROBIAL COMMUNITY; NITRIFICATION; NONHUMAN; PANDEMIC INFLUENZA; PHOSPHATE METABOLISM; PRIORITY JOURNAL; SEQUENCING BATCH REACTOR; WASTE WATER TREATMENT PLANT;

ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; BACTERIA; BIODEGRADATION, ENVIRONMENTAL; BIOREACTORS; MICROBIAL CONSORTIA; MODELS, BIOLOGICAL; OSELTAMIVIR; PANDEMICS; PARTICLE SIZE; PHOSPHORUS; SEWAGE; WASTE DISPOSAL, FLUID; WATER POLLUTANTS, CHEMICAL; WATER PURIFICATION;

BACTERIA (MICROORGANISMS);

EID: 78650766260     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2010.02163.x     Document Type: Article

References (28)

1. Accinelli C, Caracciolo AB & Grenni P (2007) Degradation of the antiviral drug oseltamivir carboxylate in surface water samples. Int J Environ An Ch 87: 579-587.
2. Accinelli C, Sacca ML, Fick J, Mencarelli M, Lindberg R & Olsen B (2010) Dissipation and removal of oseltamivir (Tamiflu) in different aquatic environments. Chemosphere 79: 891-897.
3. Amann RI (1995) In situ identification of microorganisms by whole cell hybridization with rRNA-targeted nucleic acid probes. Molecular Microbial Ecology Manual (Akkerman ADL, Elsas DJV & Bruijn FJDOD, eds), pp. 1-15. Kluwer Academic Publishers, London.
4. APHA (1998) Standard Methods for the Examination of Water and Wastewater. American Public Health Association, Washington, DC.
5. Barr JJ, Slater FR, Fukushima T & Bond PL (2010) Evidence for bacteriophage activity causing community and performance changes in a phosphorus removal activated sludge. FEMS Microbiol Ecol 74: 631-642.
6. Bartels P & von Tumpling W (2008) The environmental fate of the antiviral drug oseltamivir carboxylate in different waters. Sci Total Environ 405: 215-225.
7. Bond PL, Erhart R, Wagner M, Keller J & Blackall LL (1999) Identification of some of the major groups of bacteria in efficient and nonefficient biological phosphorus removal activated sludge systems. Appl Environ Microb 65: 4077-4084.
8. Crocetti GR, Banfield JF, Keller J, Bond PL & Blackall LL (2002) Glycogen-accumulating organisms in laboratory-scale and full-scale wastewater treatment processes. Microbiol-SGM 148: 3353-3364.
9. Daughton CG & Ternes TA (1999) Pharmaceuticals and personal care products in the environment: agents of subtle change? Environm Health Persp 107: 907-938.
10. de Kreuk MK, Kishida N & van Loosdrecht MCM (2007) Aerobic granular sludge - state of the art. Water Sci Technol 55: 75-81.
11. Fick J, Lindberg R, Tysklind M, Haemig PD, Walderstrom J, Wallensten A & Olsen B (2007) Antiviral Oseltamivir is not removed or degraded in normal sewage water treatment: implications for development of resistance by Influenza A virus. PLoS ONE 2: e986.
12. Ghosh GC, Nakada N, Yamashita N & Tanaka H (2010) Oseltamivir carboxylate, the active metabolite of oseltamivir phosphate (Tamiflu), detected in sewage discharge and river water in Japan. Environ Health Persp 118: 103-107.
13. He G, Massarella J & Ward P (1999) Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802. Clin Pharmacokinet 37: 471-484.
14. He S, Gu AZ & McMahon KD (2008) Progress toward understanding the distribution of Accumulibacter among full-scale enhanced biological phosphorus removal systems. Microb Ecol 55: 229-236.
15. Hesselmann RPX, Werlen C, Hahn D, van der Meer JR & Zehnder AJB (1999) Enrichment, phylogenetic analysis and detection of a bacterium that performs enhanced biological phosphate removal in activated sludge. Syst Appl Microbiol 22: 454-465.
16. Lim WS, Douglas G, Honeybourne D et al. (2007) Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Thorax 62: 1-46.
17. Lu HB, Oehmen A, Virdis B, Keller J & Yuan ZG (2006) Obtaining highly enriched cultures of Candidatus Accumulibacter phosphatis through alternating carbon sources. Water Res 40: 3838-3848.
18. Parker D, Soong G, Planet P, Brower J, Ratner AJ & Prince A (2009) The NanA neuraminidase of Streptococcus pneumoniae is involved in biofilm formation. Infect Immun 77: 3722-3730.
19. Prasse C, Schlusener MP, Schulz R & Ternes TA (2010) Antiviral drugs in wastewater and surface waters: a new pharmaceutical class of environmental relevance? Environ Sci Technol 44: 1728-1735.
20. Sacca ML, Accinelli C, Fick J, Lindberg R & Olsen B (2009) Environmental fate of the antiviral drug Tamiflu in two aquatic ecosystems. Chemosphere 75: 28-33.
21. Seviour RJ, Mino T & Onuki M (2003) The microbiology of biological phosphorus removal in activated sludge systems. FEMS Microbiol Rev 27: 99-127.
22. Singer AC, Nunn MA, Gould EA & Johnson AC (2007) Potential risks associated with the proposed widespread use of Tamiflu. Environ Health Persp 115: 102-106.
23. Singer AC, Johnson AC, Anderson PD & Snyder SA (2008) Reassessing the risks of Tamiflu use during a pandemic to the Lower Colorado River. Environ Health Persp 116: A285-A286.
24. Slater FR, Johnson CR, Blackall LL, Beiko RG & Bond PL (2010) Monitoring associations between clade-level variation, overall community structure and ecosystem function in enhanced biological phosphorus removal (EBPR) systems using terminal-restriction fragment length polymorphism (T-RFLP). Water Res 44: 4908-4923.
25. Soderstrom H, Jarhult JD, Fick J, Lindberg R, Singer AC, Grabic R & Olsen B (2010) Levels of antivirals and antibiotics in the river Thames, UK, during the pandemic 2009. SETAC Europe Annual Meeting, Seville.
26. Soong G, Muir A, Gomez MI et al. (2006) Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production. J Clin Invest 116: 2297-2305.
27. ®) for sewage works and surface waters under seasonal-influenza- and pandemic-use conditions. Ecotoxicol Environ Saf 72: 1625-1634.
28. Zilles JL, Peccia J, Kim MW, Hung CH & Noguera DR (2002) Involvement of Rhodocyclus-related organisms in phosphorus removal in full-scale wastewater treatment plants. Appl Environ Microb 68: 2763-2769.